Healthcare / Medical Care FacilitiesThailand
$18.40
+0.20 (+1.10%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-49.5M · quality 36.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$22.1B
P/E
8.2x
↓EV/EBITDA
6.9x
↓ROE
12.8%
↑Gross Margin
24.2%
↓Debt/Equity
0.84
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.3%
FCF CAGR
+19.7%
FCF margin
7.0%
FCF / Net income
0.37x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.75B · net income $2.80B · FCF $1.03B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.75B | $14.75B | $9.87B | $9.63B | $10.69B |
| Net Income | $2.80B | $2.80B | $727.8M | $1.55B | $2.17B |
| EBITDA | $5.45B | $5.45B | $2.35B | $3.06B | $3.90B |
| EPS | 2.33 | 2.33 | 0.61 | 1.29 | 1.81 |
| Gross Margin | 24.2% | 24.2% | 23.7% | 22.6% | 26.9% |
| Operating Margin | 8.3% | 8.3% | 9.1% | 6.4% | 12.8% |
| Net Margin | 19.0% | 19.0% | 7.4% | 16.1% | 20.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.84 | 0.84 | 0.62 | 0.59 | 0.55 |
| Current Ratio | 0.41 | 0.41 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.03B | $1.03B | $-49.5M | $-275.0M | $603.0M |
| Returns | |||||
| ROE | 12.8% | 12.8% | 4.0% | 8.4% | 11.3% |
| Valuation | |||||
| P/E | 8.21 | 8.21 | 36.28 | 32.97 | 30.02 |
| EV/EBITDA | 6.91 | 6.91 | 15.69 | 19.82 | 19.06 |
| P/B | 1.01 | 1.01 | 1.44 | 2.76 | 3.39 |
| Growth & Yield | |||||
| Revenue Growth | 49.5% | 49.5% | 2.4% | -9.8% | — |
| EPS Growth | 282.0% | 282.0% | -52.7% | -28.7% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-11.2%
EPS terminal req.
$1.63
Spread vs growth
293.1%
5Y implied EPS CAGR
-3.2%
EPS terminal req.
$1.98
Spread vs growth
285.2%
10Y implied EPS CAGR
3.2%
EPS terminal req.
$3.18
Spread vs growth
278.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+3.4%
Start / end P/E
29.3x → 7.9x
EPS bridge
0.61 → 2.33
Residual
-206.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.